AstraZeneca's key lung cancer drug wins European panel thumbs-up

AstraZeneca's cancer drug Imfinzi has won a key recommendation from a European Medicines Agency (EMA) panel less than six months after the first global approvals in Western markets.

from Reuters: Health https://ift.tt/2Af3zOp
via IFTTT

• Tweet
• Share
• Share
• Share
• Share